# UNIVERSITY OF ALABAMA AT BIRMINGHAM: Medications for opioid use disorder differentially modulate intrinsically photosensitive retinal ganglion cell function, sleep, and circadian rhythms: implications for treatment

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF ALABAMA AT BIRMINGHAM |
| Location | BIRMINGHAM, AL |
| Project | Medications for opioid use disorder differentially modulate intrinsically photosensitive retinal ganglion cell function, sleep, and circadian rhythms: implications for treatment |
| Project number | 5R01DA059471-04 |
| Mechanism | R01 |
| Institute | National Institute on Drug Abuse |
| Award | $1,098,863 |
| Awarded | 2026-08-27 |
| Project period | 2023-09-30 to 2027-08-31 |
| UEI | YND4PLMC9AN7 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11385457). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.